After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
PRGO belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Perrigo Company plc is $2.86B. A total of 2.38 million shares were traded on the day, compared to an average of 1.48M shares.
In the most recent transaction, Lennox Abigail bought 1,255 shares of PRGO for 22.41 per share on Sep 08 ’25. After the transaction, the EVP and CSO now owns 1,255 company shares. In a previous transaction on Sep 05 ’25, Atkinson Charles bought 1,000 shares at 23.20 per share. PRGO shares that EVP, General Counsel & Sec. owns now total 1,000.
Among the insiders who bought shares, Willis Robert acquired of 1,488 shares on Aug 22 ’25 at a per-share price of $24.10. This resulted in the EVP & CHRO holding 41,939 shares of PRGO after the transaction. In another insider transaction, Parker Geoffrey M. bought 4,375 shares at $22.97 per share on Aug 18 ’25. Company shares held by the Director now total 33,287.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, PRGO has a high of $30.93 and a low of $20.95.
As of this writing, PRGO has an earnings estimate of $0.77 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of $0.82 per share and a lower estimate of $0.75. The company reported an EPS of $0.81 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. PRGO’s latest balance sheet shows that the firm has $1.86B in Cash & Short Term Investments as of fiscal 2021. There were $3.69B in debt and $1.59B in liabilities at the time. Its Book Value Per Share was $32.50, while its Total Shareholder’s Equity was $5.15B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRGO is Buy with a score of 3.80.
